Gain Therapeutics, Inc. (GANX)
NASDAQ·Healthcare·Biotechnology
$1.76
+0.57%
Mkt Cap $75.07M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$9.00
Range $8.00 – $10.00
Implied Upside
+411.4%
Consensus $9.00 vs current $1.76
NASDAQ·Healthcare·Biotechnology
$1.76
+0.57%
Mkt Cap $75.07M
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$9.00
Range $8.00 – $10.00
+411.4%
Consensus $9.00 vs current $1.76